Global Image-Guided Radiation Therapy Market Insights Forecasts to 2032

• The Global Image-Guided Radiation Therapy Market Size was valued at USD 1.78 Billion in 2022.
• The Market Size is Growing at a CAGR of 5.1% from 2022 to 2032
• The Worldwide Image-Guided Radiation Therapy Market Size is expected to reach USD 2.93 Billion by 2032
• Asia Pacific is expected to Grow at a significant pace during the forecast period

The Global Image-Guided Radiation Therapy Market Size is anticipated to exceed USD 2.93 Billion by 2032, Growing at a CAGR of 5.1% from 2022 to 2032. The increasing need for image-guided interventions and growth in non-invasive cancer management treatments are a few of the drivers contributing to the growth of the image-guided radiation therapy market.          

Market Overview

IGRT is a cutting-edge technology that uses radiation therapy in conjunction with advanced imaging techniques to precisely target and treat cancerous tumors. This method improves radiation therapy accuracy and effectiveness while minimizing damage to surrounding healthy tissues. Real-time imaging, such as X-rays, CT scans, or MRI, is used to guide radiation therapy delivery in IGRT. It enables oncologists to monitor and adjust a patient's treatment plan in response to changes in anatomy or tumor position during treatment. This level of accuracy is especially important in the treatment of cancers that are close to vital organs or structures. The increasing incidence of cancer worldwide, the growing demand for personalized treatment plans, and technological advancements in both imaging and radiation therapy equipment are driving the global IGRT market. This market includes a variety of components, such as imaging systems, software solutions, and radiation therapy machines, all of which contribute to overall improvements in patient outcomes.

Report Coverage

This research report categorizes the market for the global image-guided radiation therapy market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the image-guided radiation therapy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the image-guided radiation therapy market.

Driving Factors

The continuous improvement in the precision and accuracy of radiation therapy is one of the primary drivers of the IGRT market. Advances in technology have resulted in the development of sophisticated imaging modalities such as MRI, CT scans, PET scans, and cone-beam CT (CBCT), which can provide real-time, high-resolution images of the tumor and surrounding tissues. Oncologists can use these images to precisely locate and target tumors, reducing damage to healthy tissues and side effects. ART is a sophisticated IGRT technique that adapts the radiation treatment plan in real time to changes in the patient's anatomy or tumor position. ART technological advancements enable dynamic changes during treatment sessions. This ensures that the radiation beams are directed at the tumor consistently, even if it shifts due to factors such as breathing or body movement. ART improves treatment efficacy while reducing radiation exposure to nearby healthy tissues.

Restraining Factors

Implementing IGRT in healthcare facilities necessitates a significant capital investment. This includes the purchase of specialized IGRT equipment such as imaging-capable linear accelerators, advanced imaging devices (e.g., CT scanners, MRI machines), and computer systems with sophisticated software for treatment planning and image analysis. These initial costs can be prohibitively expensive for many healthcare institutions, particularly those in resource-constrained areas or with smaller facilities.

Market Segmentation

The Global Image-Guided Radiation Therapy Market share is classified into product and procedure.

• The MRI-guided radiotherapy segment is expected to hold a significant share of the global image-guided radiation therapy market during the forecast period.     

The global image-guided radiation therapy market is categorized by product into 4D RT, LINAC, MRI-guided radiotherapy, Portal CT Imaging. Among these, the MRI-guided radiotherapy segment is expected to hold a significant share of the global image-guided radiation therapy market during the forecast period. MRI integration allows for timely treatment response assessment, allowing providers to quickly adapt plans. This improves outcomes and the precision of interventions. Real-time insights improve decision-making and raise the profile of IGRT, which aligns with patient-centric values. This collaboration establishes MRI and IGRT as essential components of advanced cancer care.    

• The stereotactic segment is expected to grow at the rapid pace in the global image-guided radiation therapy market during the forecast period.        

Based on the procedure, the global image-guided radiation therapy market is divided into IMRT, stereotactic, and particle. Among these, the stereotactic segment is expected to grow at the rapid pace in the global image-guided radiation therapy market during the forecast period. The efficiency of stereotactic therapy in requiring fewer treatment sessions compared to conventional methods aligns with the streamlined approach of IGRT. Patients, healthcare providers, and resource allocation all benefit from this, which improves patient satisfaction and adherence. This convergence emphasizes IGRT's tactical value, solidifying its market prominent position as an essential modality for efficient and effective cancer care.         

Regional Segment Analysis of the Global Image-Guided Radiation Therapy Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the Global Image-Guided Radiation Therapy Market over the predicted timeframe.

North America is projected to hold the largest share of the global image-guided radiation therapy market over the predicted years. In 2022, North America, which included the United States and Canada, held the biggest share of the image-guided radiation therapy market. North America, with its resilient healthcare infrastructure and access to cutting-edge medical technologies, is a perfect setting for the widespread use of advanced treatment methodologies such as image-guided radiation therapy (IGRT).  

Asia Pacific is expected to grow at a significant pace in the global image-guided radiation therapy market during the forecast period. The Asia-Pacific region, which includes China, Japan, India, and others, is experiencing substantial expansion in the IGRT market. Population growth, rising cancer cases, and the development of healthcare infrastructure are all factors contributing to this growth. Some APAC countries, most notably China and India, are emerging as significant IGRT markets. These countries are investing in healthcare facility modernization and expanding access to advanced cancer treatments.   

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global image-guided radiation therapy along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Siemens Healthineers AG
• Hitachi
• Elekta
• Koninklijke Philips
• Viewray Technologies Inc.
• C-RAD
• Varian Medical Systems
• Toshiba Corporation
• General Electric Healthcare Company
• IBA Worldwide
• Accuray Incorporated
• Becton, Dickinson And Company  
• Vision RT Ltd. 
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2023, Philips expanded its mobile C-arm portfolio with Zenition 10.

• In April 2023, The introduction of Pixxoscan expands GE HealthCare's portfolio of Magnetic Resonance Imaging (MRI) contrast agents, giving customers access to two leading macrocyclic molecules: Clariscan (gadoteric acid) and Pixxoscan (gadobutrol).

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2032. Spherical Insights has segmented the Global Image-Guided Radiation Therapy Market based on the below-mentioned segments: 

Global Image-Guided Radiation Therapy Market, By Product

• 4D RT
• LINAC
• MRI-guided radiotherapy
• Portal CT Imaging

Global Image-Guided Radiation Therapy Market, By Procedure

• IMRT
• Stereotactic
• Particle

Global Image-Guided Radiation Therapy Market, By Application

• Neck
• Prostate
• Breast cancer

Global Image-Guided Radiation Therapy Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa